Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03 (Perfluorohexyloctane Ophthalmic Solution) For the Treatment of Dry Eye Disease in Japan
OSAKA, Japan & HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Fifth paragraph, the number in the quote should read: 10 million units sold instead of 10,000...